The occurrence of neointimal hyperplasia after flow-diverter implantation is associated with cardiovascular risks factors and the stent design.
Caroff J, Iacobucci M, Rouchaud A, Mihalea C, de Carvalho FM, Jocson VED, Chalumeau V, Da Ros V, King RM, Arslanian R, Ikka L, Ben Achour N, Moret J, Spelle L. The occurrence of neointimal hyperplasia after flow-diverter implantation is associated with cardiovascular risks factors and the stent design. J Neurointerv Surg. 2019 Jun; 11(6):610-613.